Cti biopharma 10k
WebIn May 2014, we changed our name from “Cell Therapeutics, Inc.” to “CTI BioPharma Corp.” We completed our initial public offering in 1997 and our shares are listed on The … WebAug 24, 2024 · CTI BioPharma Corp. Aug 24, 2024, 07:00 ET. SEATTLE, Aug. 24, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced the appointment of Diane Parks to its Board of Directors. Ms.
Cti biopharma 10k
Did you know?
WebApr 12, 2024 · CTI BioPharma saw a increase in short interest in March. As of March 15th, there was short interest totaling 15,970,000 shares, an increase of 18.3% from the previous total of 13,500,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price ... WebMar 1, 2024 · We opine that CTI BioPharma's current set-up represents an attractive risk-reward scenario with ~50% potential downside (around cash value of $1/share) and ~320% potential upside (bull case $7.6 ...
WebApr 10, 2024 · CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood … WebJun 4, 2024 · CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood …
WebSector Healthcare More. 201-500 Employees. Based in Seattle, Washington. CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel … WebAs of June 30, 2024 , the aggregate market value of the registrant’s common equity held by non-affiliates was approximately $252.1 million. Shares of common stock held by each e
WebJun 1, 2024 · CTI BioPharma Investor Contacts: Argot Partners +212-600-1902 [email protected] SOURCE CTI BioPharma Corp. Related Links. ctibiopharma.com.
WebJob Openings. We are passionate about making a difference for patients with blood-related cancers. The CTI team has an unwavering motivation to deliver new therapies that have the potential to transform the lives of patients and families facing blood-related cancers. We approach our work with passion, resilience and integrity in a collaborative ... inches hdWebApr 6, 2024 · americanbankingnews.com - March 14 at 5:54 AM. Analysts Offer Insights on Healthcare Companies: CTI BioPharma (CTIC) and Aclaris Therapeutics (ACRS) markets.businessinsider.com - March 9 at 11:42 PM. CTI BioPharma Corp. (NASDAQ:CTIC) Q4 2024 Earnings Call Transcript. finance.yahoo.com - March 8 at 9:52 … inches healthcare pvt ltdWebGet the latest CTI BioPharma Corp (CTIC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. inches height to metersWeb2 days ago · Evolution of the average Target Price on CTI BIOPHARMA CORP. Target Price consensus revisions : last 18 months: Recommendations (Chart) CTI BIOPHARMA CORP. Analyst Recommendations on CTI BIOPHARMA CORP. 2024: SVB Securities Starts CTI BioPharma at Outperform with $13 Price Target ... inches hash markWebMay 13, 2024 · Shares of CTI BioPharma ( CTIC 0.23%) moved sharply higher after the drugmaker reported first-quarter results Friday morning. Investors were pleased with the initial sales figures for Vonjo, its ... inches healthcare pvt. ltdWebMar 31, 2024 · Cti Biopharma Corp (CTIC) SEC Filing 10-K Annual Report for the fiscal year ending Friday, December 31, 2024 inches have two dashesWebApr 7, 2024 · CTI BioPharma Corp does not have a meaningful P/E due to negative earnings over the last 12 trailing months. CTI BioPharma Corp’s trailing 12-month revenue is $53.9 million with a -172.4% profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-0.216 per share for the … inches height baby carriage